N14.2
Conditions
Interventions
Group 1: When patient comes to allogenic kidney transplantation they get informed about the study and if they agree to participate by informed consent 2x2,5 ml EDTA blood is taken and midstream urine
Sponsors
Universitätsmedizin Rostock,Urologische Klinik und Poliklinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - age at least 18 year - informed consent - cadaveric kidney transplantation due to chronic kidney failure
Exclusion criteria
Exclusion criteria: - multiple organ transplantations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - description of BKPyV replication in urine and plasma one year following kidney transplantation as well as infection and retention paraclinics - description of celluar immune response and cytokine release in BKPyV replication - description of virus specific micro-RNA in urine and plasma | — |
Secondary
| Measure | Time frame |
|---|---|
| - development of an panel of biomarkers for risk assessment in BKPyV infection and development of nephropathy or graft loss | — |
Countries
Germany
Contacts
Public ContactLaila Schneidewind
Universitätsmedizin Rostock,Urologische Klinik und Poliklinik
Outcome results
None listed